Stock EMBC EMBECTA CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Embecta Corp.

Equities

EMBC

US29082K1051

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
10.44 USD +1.26% Intraday chart for Embecta Corp. -4.04% -44.85%
Feb. 09 Embecta Keeps Quarterly Dividend at $0.15 a Share, Payable March 15 to Shareholders as of Feb. 28 MT
Feb. 09 Sector Update: Health Care Stocks Mixed Pre-Bell Friday MT

Valuation

Fiscal Period: September 2022 2023 2024 2025 2026
Capitalization 1 1,665 862.4 593.6 - -
Enterprise Value (EV) 1 2,978 2,139 1,726 1,606 1,472
P/E ratio 7.4 x 12.3 x 11.7 x 6.12 x 5.59 x
Yield 0.52% 3.99% 5.42% 5.39% 5.48%
Capitalization / Revenue 1.47 x 0.77 x 0.53 x 0.53 x 0.53 x
EV / Revenue 2.64 x 1.91 x 1.55 x 1.44 x 1.3 x
EV / EBITDA 6.48 x 5.65 x 5.27 x 4.87 x 4.4 x
EV / FCF - - - - -
FCF Yield - - - - -
Price to Book -1.84 x -1.06 x -0.85 x -1.05 x -1.45 x
Nbr of stocks (in thousands) 57,836 57,304 57,579 - -
Reference price 2 28.79 15.05 10.31 10.31 10.31
Announcement Date 12/20/22 11/21/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: September 2021 2022 2023 2024 2025 2026
Net sales 1 1,165 1,130 1,121 1,110 1,114 1,130
EBITDA 1 - 459.9 378.7 327.4 329.4 334.4
EBIT 1 - 309.6 221.5 272.9 273.4 279.8
Operating Margin - 27.41% 19.76% 24.58% 24.53% 24.75%
Earnings before Tax (EBT) 1 - 256.6 105.7 152.8 158.6 -
Net income 1 415 223.6 70.4 51 99.6 110.3
Net margin 35.62% 19.8% 6.28% 4.59% 8.94% 9.76%
EPS 2 - 3.890 1.220 0.8800 1.685 1.845
Free Cash Flow - - - - - -
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share 2 - 0.1500 0.6000 0.5590 0.5556 0.5650
Announcement Date 12/21/21 12/20/22 11/21/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: September 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 291.1 274.6 275.7 277.1 286.1 281.9 277.3 264.7 283.8 281.5 276.3 267.4
EBITDA 1 117.9 87.2 110.2 96.7 92.2 79.6 90.4 71.84 84.32 81.08 85.05 82
EBIT 1 97.1 -3 101.6 84.9 51.3 25.8 77.5 56.56 68.88 66.29 67.8 65.45
Operating Margin 33.36% -1.09% 36.85% 30.64% 17.93% 9.15% 27.95% 21.37% 24.27% 23.55% 24.54% 24.48%
Earnings before Tax (EBT) - -27.5 56.1 24.5 20.1 5 14.3 - - - 41 39
Net income 1 62.4 -17.2 35.2 14 15.2 6 20.1 4.3 13.7 13.45 23 22.1
Net margin 21.44% -6.26% 12.77% 5.05% 5.31% 2.13% 7.25% 1.62% 4.83% 4.78% 8.33% 8.26%
EPS 2 1.070 -0.3000 0.6100 0.2400 0.2600 0.1000 0.3500 0.0700 0.2300 0.2300 0.3900 0.3750
Dividend per Share 2 - - - - 0.1500 0.1500 0.1500 0.1500 0.1500 0.1500 0.1500 0.1500
Announcement Date 8/15/22 12/20/22 2/14/23 5/12/23 8/8/23 11/21/23 2/9/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: September 2021 2022 2023 2024 2025 2026
Net Debt 1 - 1,313 1,277 1,132 1,012 879
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) - 2.855 x 3.372 x 3.458 x 3.072 x 2.627 x
Free Cash Flow - - - - - -
ROE (net income / shareholders' equity) - - - - - -
ROA (Net income/ Total Assets) - - - - - -
Assets 1 - - - - - -
Book Value Per Share 2 - -15.60 -14.20 -12.20 -9.780 -7.110
Cash Flow per Share 2 - 7.170 1.170 0.5700 3.420 -
Capex - - - - - -
Capex / Sales - - - - - -
Announcement Date 12/21/21 12/20/22 11/21/23 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Embecta Corp.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
4
Last Close Price
10.31 USD
Average target price
16.5 USD
Spread / Average Target
+60.04%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
EMBECTA CORP. Stock Embecta Corp.
-44.85% 594M
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.54% 187B
MEDTRONIC PLC Stock Medtronic plc
-1.85% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-4.26% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+1.39% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+16.82% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+3.49% 26.48B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+0.65% 26.25B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. EMBC Stock
  4. Financials Embecta Corp.